COVID-19 Vaccine-Induced Cardiac Arrest

GlobalResearch.ca

Dr. Peter McCullough

We continue to see vaccinated persons suffer cardiac arrests three years after most took the shots in 2021. Both Pfizer and Moderna mRNA have been found in human heart muscle at autopsy. Spike protein has been stained in biopsy samples of young men suffering from myocarditis.

Victims have been found to have circulating Spike protein but ineffective antibodies, probably IgG4 subclass, that fail to neutralize Spike and allow its assault on the heart.

Positron emission tomography data have disclosed a shift from free fatty acid to glucose in the human heart of virtually everyone who has taken a COVID-19 vaccine.

The PET pattern looks like global ischemia. This could be due to vaccine Spike protein hemagglutination in myocardial capillaries or cellular changes in mitochondrial respiration and substrate metabolism. Small patches of dysfunctional, inflamed, or scarred myocardium are sufficient to serve as a nidus for re-entrant ventricular tachycardia that can degrade to ventricular fibrillation and lead to cardiac arrest.

Hulscher et al have demonstrated cardiac arrest within a few weeks of vaccination is caused by vaccine myocarditis with no prior premonitory phase that allows for detection.

With the passage of time, we have learned much from the clinical evaluation of a large number, 5-10% of vaccine victims, who have symptoms months to years after injection.

Among those with clinical myocarditis early after injection and reported to VAERS, Rose et al has reported a mortality rate of 2.9%.

Determinants of COVID-19 vaccine-induced myocarditis - PubMed

COVID-19 vaccination is strongly associated with a serious adverse safety signal of myocarditis, particularly in children and young adults resulting in hospitalization and death. Further investigation into the underlying mechanisms of COVID-19 vaccine-induced myocarditis is imperative to create effe …

PubMedJessica Rose

Takada et al have reported the mortality rate of COVID-19 vaccine myopericarditis in the Japanese Drug Adverse Event Reporting System is 9.6% at 62 days.

SARS-CoV-2 mRNA vaccine-related myocarditis and pericarditis: An analysis of the Japanese Adverse Drug Event Report database - PubMed

In the Japanese population, SARS-CoV-2 mRNA vaccination was significantly associated with the onset of myocarditis/pericarditis. The influencing factors included age of ≤30 years and male. Furthermore, although most adverse events occurred early after vaccination, overall outcomes were good.

PubMedKeisuke Takada

Original Article: https://www.globalresearch.ca/future-cardiac-arrest-covid-19-vaccination/5865203